Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 8/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14294716 | 0.90 | SCN9A (0.39) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL23208327 | 0.90 | SCN9A (0.35) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL14294661 | 0.88 | ALDH1A1 (0.37) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL10225066 | 0.88 | SCN9A (0.35) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL20886327 | 0.88 | SCN9A (0.34) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL20886369 | 0.87 | SCN9A (0.34) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL20886397 | 0.87 | SCN9A (0.33) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL13467028 | 0.87 | SCN9A (0.43) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL785687 | 0.86 | SCN9A (0.32) | SCN9A | |
| SCHEMBL686864 | 0.85 | ALDH1A1 (0.39) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| US-7531686-B2 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-12 | — | — | US | disclosed |
| US-20070100158-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146930-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, FGFR1, NHERF1 | SCN9A 185/4885ALDH1A1 861/4885MEN1 2209/4885 |
| US-20070100158-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SLC26A3, RFC1, RFC2 | SCN9A 215/4885ALDH1A1 1641/4885MEN1 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.